Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178253-17-000007
Filing Date
2017-05-08
Accepted
2017-05-08 16:02:18
Documents
65
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm 10-Q 656846
2 EXHIBIT 12.1 exhibit121-33117.htm EX-12.1 166681
3 EXHIBIT 31.1 exhibit311-33117.htm EX-31.1 12094
4 EXHIBIT 31.2 exhibit312-33117.htm EX-31.2 11993
5 EXHIBIT 32.1 exhibit321-33117.htm EX-32.1 8693
  Complete submission text file 0001178253-17-000007.txt   4625725

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT scyx-20170331.xml EX-101.INS 827615
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT scyx-20170331.xsd EX-101.SCH 40394
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT scyx-20170331_cal.xml EX-101.CAL 65757
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT scyx-20170331_def.xml EX-101.DEF 181246
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT scyx-20170331_lab.xml EX-101.LAB 518473
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT scyx-20170331_pre.xml EX-101.PRE 325553
Mailing Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548
Business Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36365 | Film No.: 17822181
SIC: 2834 Pharmaceutical Preparations